The amyloid hypothesis was originally proposed largely based on the compelling genetic evidence: familial mutations in genes encoding for amyloid precursor protein (APP) or presenilin are associated with the early onset of AD in humans, resulting in increased Aβ production and amyloid plaque pathology [4]. This evidence concerns the gene APP and Alzheimer disease.